SCHEMBL171849

SCHEMBL171849

Nc1ccc(Cc2ccnc3cc(-c4ccc(C5OCCCO5)cn4)sc23)c(F)c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADRA2B P18089 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17993507 0.93 ADRA2B (0.32) ADRA2B
SCHEMBL13927595 0.87
SCHEMBL106446 0.82 MET (0.40)
SCHEMBL103259 0.78 MET (0.41)
SCHEMBL106882 0.77 KDM1A (0.35)
SCHEMBL12286388 0.75 MST1R (0.39)
SCHEMBL106586 0.72 KDM1A (0.36)
SCHEMBL10172437 0.72 CCNB2 (0.35)
SCHEMBL14230491 0.72 MET (0.46) ADRA2B
SCHEMBL21383117 0.71 MST1R (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426108-A1 Processes and intermediates for preparing fused heterocyclic kinase inhibitors MethylGene Inc. (CA) 2012-03-07 EP disclosed
EP-2332536-A1 Inhibitors of protein tyrosine kinase activity MethylGene Inc. (CA) 2011-06-15 EP disclosed